Search - tctmd.com

Displaying 321 - 340 of 448

Sort: Relevancy | Date

News Daily News

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

Todd Neale

September 13, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Daily News

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Caitlin E. Cox

August 17, 2016

News Industry News

Spectranetics Receives CE Mark for AngioSculptX™

August 11, 2016

News Industry News

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

July 07, 2016

News Daily News

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Caitlin E. Cox

July 07, 2016

News Industry News

Arizona patient will receive first U.S.-approved fully dissolving heart stent

July 06, 2016

News Industry News

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

June 28, 2016

News Daily News

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

Todd Neale

June 16, 2016

News Industry News

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

June 06, 2016

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Industry News

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

April 07, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

News Industry News

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

January 06, 2016

News Daily News

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Yael L. Maxwell

December 13, 2015

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

Advertisement

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

TCTMD’s Top 10 Most Popular Stories for August 2016

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Spectranetics Receives CE Mark for AngioSculptX™

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Arizona patient will receive first U.S.-approved fully dissolving heart stent

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content